Ovarian cancer trials in Bulgaria

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  Where

  Panagyurishte, Sofia

  Age

  18 years and over

  People

  172 worldwide

  Run by

  K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

  See details and how to joinNCT04516447 · EU 2025-524868-38-00
• Phase 3Taking people
  Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

  Where

  Dobrich, Plovdiv, Shumen, Sofia

  Age

  18 years and over

  People

  950 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07851025 · EU 2026-526895-22-00
• Phase 3Taking people
  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  Where

  Branipole, Plovdiv, Sofia, Sofiya

  Age

  18 years and over

  People

  582 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06819007 · EU 2024-516982-35-00